Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Institutional National Research Service Award (T32)
Project #
5T32MH017047-08
Application #
3542542
Study Section
Mental Health Research Education Review Committee (RER)
Project Start
1982-09-01
Project End
1990-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Bitting, L; Sutin, E L; Watson, F L et al. (1994) C-fos mRNA increases in the ground squirrel suprachiasmatic nucleus during arousal from hibernation. Neurosci Lett 165:117-21
Harrington, M A; Shaw, K; Zhong, P et al. (1994) Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors. J Pharmacol Exp Ther 268:1098-106
Milburn, C M; Prince, D A (1993) Postnatal development of cholinergic presynaptic inhibition in rat hippocampus. Brain Res Dev Brain Res 74:133-7
Agmon, A; Connors, B W (1992) Correlation between intrinsic firing patterns and thalamocortical synaptic responses of neurons in mouse barrel cortex. J Neurosci 12:319-29
Harrington, M A; Sleight, A J; Pitha, J et al. (1991) Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivity. Eur J Pharmacol 194:83-90
Agmon, A; Connors, B W (1991) Thalamocortical responses of mouse somatosensory (barrel) cortex in vitro. Neuroscience 41:365-79
Deliganis, A V; Pierce, P A; Peroutka, S J (1991) Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. Biochem Pharmacol 41:1739-44
Harrington, M A; Peroutka, S J (1990) Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues. J Neurochem 54:294-9
Harrington, M A; Peroutka, S J (1990) Differential modulation of 5-hydroxytryptamine1D binding sites by GTP and GTPgammaS. Brain Res 506:172-4
Slaughter, J L; Harrington, M A; Peroutka, S J (1990) 6-substituted tricyclic partial ergoline compounds are selective and potent 5-hydroxytryptamine1A receptor agents. Life Sci 47:1331-7

Showing the most recent 10 out of 28 publications